Maitake Mushroom for Dogs: Evidence and Safety

Vet verified.

Maitake can be included in a dog-specific mushroom formula, but it should not be presented as a cancer treatment or a proven stand-alone therapy. A small canine study tested one proprietary Maitake extract in dogs with lymphoma and found no objective responses. That result cannot be converted into a benefit claim for a different multi-ingredient chew.

Finch & Barker includes Maitake in an adult-dog blend intended to support everyday immune health, digestion, mobility and vitality. The product does not diagnose, treat, cure or prevent disease.

What is Maitake?

Maitake is the common name for Grifola frondosa. It grows in layered clusters and is used as both a culinary mushroom and an ingredient in concentrated preparations. A fresh food portion, dried powder, standardized fraction and multi-mushroom chew are not interchangeable.

When a label says Maitake, look for the full product context. The species name, preparation, amount, added ingredients, life stage and directions determine what is actually being given.

https://cdn.shopify.com/s/files/1/1032/3712/4438/files/maitake-mushroom-ingredient-guide.png?v=1789151458

What did the canine Maitake study test?

A 2007 prospective noncontrolled clinical trial enrolled fifteen dogs with confirmed intermediate- or high-grade lymphoma. Researchers administered a specific Maitake-derived PETfraction at 3 drops per kilogram per day, divided into two doses, and planned evaluations through twelve weeks.

The study did not test Finch & Barker Mushroom Chews, a culinary serving or generic Maitake powder. It also did not include a placebo or untreated comparison group.

What were the results?

No dog achieved the study's objective response threshold of more than a 50% decrease in lymph-node size. Thirteen dogs developed progressive disease before week four. The median treatment duration was 27 days, with a range of 9 to 228 days.

The authors reported that the extract was generally accepted and minimal adverse effects were observed, but two dogs developed hyphema. The report could not determine whether that eye finding came from progressive disease or the tested treatment. The correct conclusion is narrow: this small uncontrolled trial found no objective responses to that specific Maitake fraction.

https://cdn.shopify.com/s/files/1/1032/3712/4438/files/veterinary-maitake-study-review.png?v=1789151465

What the study cannot prove

• It does not show that ordinary Maitake treats or prevents lymphoma.
• It does not prove a benefit for Finch & Barker Mushroom Chews.
• It does not establish a preventive serving for healthy dogs.
• It does not compare Maitake with chemotherapy or another standard treatment.
• It does not make findings from cells or mice into a clinical outcome for pet dogs.

A product page should never use the diagnosis in this study as a sales angle. A dog with a mass, enlarged lymph node, weight loss, reduced appetite or another persistent sign needs diagnosis and treatment planning, not a supplement experiment.

How Finch & Barker uses Maitake

Maitake is one of seven named mushrooms in Finch & Barker Mushroom Chews, alongside Real Turkey Tail™, Reishi, Lion's Mane, Chaga, Shiitake and Cordyceps. Turmeric extract is also part of the formula. The chew is for eligible adult dogs and has weight-based directions.

When veterinary review is essential

Speak with the treating veterinarian before any supplement when a dog has cancer or is being evaluated for it. The same applies to dogs taking prescription or over-the-counter medication, preparing for surgery, living with a chronic condition, following a therapeutic diet, or experiencing an unexplained symptom.

Bring the whole label and medication list. Multi-ingredient products should be reviewed as complete formulas, not ingredient by ingredient in isolation. Never stop, delay or adjust prescribed care because a mushroom is described as functional.

How to evaluate a Maitake product

1. Confirm that it is intended for dogs and the correct life stage.
2. Check that Maitake and every other active ingredient are named.
3. Read the amount and directions for the exact format.
4. Reject claims to shrink tumors, replace medication or cure disease.
5. Check for duplicated mushrooms, turmeric or herbal ingredients.
6. Keep the container, lot details and start date.

The FDA explains that claims to cure, treat, prevent or mitigate disease may indicate that an animal product is being offered as a new animal drug. Marketing language does not replace the evidence and approval required for that intended use.

Maitake food is different from a supplement

A small plain cooked grocery-store Maitake portion is a food exposure. A dried extract or standardized fraction is a concentrated product with different instructions. Do not use a grocery mushroom to imitate a supplement formula or use a human extract to recreate a study serving.

Review our guide to culinary and wild mushrooms for dogs, compare functional mushroom preparations, use the mushroom supplement label checklist and browse more dog supplement guides.

Frequently asked questions

Is Maitake safe for dogs?

A dog-specific formula may include Maitake, but suitability depends on the complete product and the individual dog. Follow the label and ask a veterinarian when medication, illness or a planned procedure is involved.

Does Maitake treat cancer in dogs?

No approved claim supports that use for Finch & Barker. A small uncontrolled study of a specific Maitake fraction found no objective responses in fifteen dogs with lymphoma.

Can Maitake replace chemotherapy?

No. Do not delay or replace oncology treatment with a mushroom product. Discuss every supplement with the treating veterinary oncologist.

Can I copy the dose from the Maitake study?

No. The trial used a specific proprietary fraction and study protocol. It does not provide directions for another powder, food or chew.

Can puppies take Finch & Barker Mushroom Chews?

No. The current product is intended for eligible adult dogs.